Sunil Godhwani responsible for Group’s woes: Singh Brothers

NEW DELHI: Former promoters of Fortis Healthcare and Religare Malvinder Singh and Shivinder Singh today blamed former Religare Enterprises Chairman and Managing Director Sunil Godhwani for the group’s troubles.

“The Group’s troubles today stem from the Group’s association with Sunil Godhwani who had started his association in Religare as its CEO in 2001,” Malvinder Singh and Shivinder Singh said in a joint statement.

Godhwani had stepped down as the chairman and MD in July 29, 2016. Subsequently, he assumed charge of the CEO in Religare Enterprises.

After the Ranbaxy sale closed in 2008, it was decided that Godhwani will lead our family office in addition to his role in Religare, and from 2008-end, he had full management control of RHC Holding and its subsidiaries, it added.

He was expected to be a responsible trustee and steward of the family’s resources and consequently our reputation, the statement said.

“Godhwani used his position to conceive and orchestrate a series of transactions over the better part of a decade that led to our Group’s debt load by 2016,” it added.

It is clear that he used our trust in him to exercise undue influence and has taken advantage of the faith bestowed by both families, the statement said.

“We are sure (Gurinder Singh) Dhillon and his family would have had a similar expectation from Godhwani regarding management of their resources,” it added.

Gurinder Singh Dhillon is the spiritual guru of the Radha Soami Satsang Beas (RSSB).

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials

    Different packaging, typos expose fake Mounjaro racket

    Different packaging, typos expose fake Mounjaro racket

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection